GlassScriptPhysician profile
Charles L Newman
NPI 1093772162
$122,834.01
in general payments reported to CMS, 2019-2025
21 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $117 · 2021: $337 · 2022: $6,676 · 2023: $35K · 2024: $51K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $91K · Travel and Lodging: $19K · Food and Beverage: $5,406 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $91,212.50 |
| Travel and Lodging | $18,960.69 |
| Food and Beverage | $5,406.38 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $113,950.37 | 2023-2025 | |
| Intuitive Surgical, INC. | $6,570.73 | 2021-2023 | Da Vinci Surgical System |
| Prime Surgical, LLC | $618.32 | 2023 | |
| Ethicon US, LLC | $557.98 | 2019-2025 | Evarrest, Vistaseal, Mega Soft |
| Arthrex, INC. | $252.08 | 2023 | |
| Davol INC. | $241.35 | 2019-2022 | |
| Triad Life Sciences INC. | $185.48 | 2021-2022 | |
| Melinta Therapeutics, LLC | $63.57 | 2021-2022 | |
| Axonics, INC. | $62.41 | 2023-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $46.67 | 2024 | Venaseal |
| Kci USA, INC. | $42.81 | 2020-2023 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Kerecis Limited | $41.40 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Conmed Corporation | $31.51 | 2020-2022 | |
| Cook Medical LLC | $29.22 | 2019 | |
| Braintree Laboratories, INC. | $26.56 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $26.02 | 2025 | V.A.C. Veraflo, Activ.A.C., Prevena |
| Bioventus LLC | $19.92 | 2022 | |
| Tela Bio, INC. | $19.46 | 2022 | |
| Tei Biosciences INC | $16.57 | 2019 | |
| Shionogi INC | $15.85 | 2021 | |
| Galderma Laboratories, L.P. | $15.73 | 2023 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.